Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.

The S&P 500 finished slightly higher, up just 0.01%.

Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.

Happy Monday! These are the headlines you need to see during your morning commute.

Stock futures are mostly lower as benchmark 10-year Treasury notes inch closer to 3%; Google parent Alphabet, T-Mobile US and Hasbro report earnings; Akorn plunges after Germany's Fresenius drops its planned $5 billion takeover of the generic drugmaker.

The U.S. earnings seasons accelerates this week with 180 S&P 500 companies reporting, including big tech names such as Google, Facebook, Amazon and Microsoft.

Germany's Fresenius SE said a probe into alleged data breaches at Akorn could scupper its planned $5 billion takeover of the Lake Forest, Ill.-based generic drugmaker.

Global stocks were mixed in early Tuesday trading as investors sifted through prepared remarks ahead of the first of two appearances on Capitol Hill this week by new Fed chairman Jerome Powell.

Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila.

The takeover of the budget airline raises a key question for consumers.

Nvidia provided negative news on Monday and Micron followed up with more on Tuesday. Here's the trade.

Retailing giant Walmart wants to ensure its customers can get what they're looking for, however they want to buy it.